Log in to your Inderes Free account to see all free content on this page.
Optomed
3.905
EUR
+2.9 %
5,450 following
OPTOMED
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
+2.9%
-13.61%
-16.2%
-16.29%
-21.27%
-8.12%
-33.81%
+1.96%
-14.74%
Optomed is a medical technology company. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that is resold under different brands. The company operates worldwide, with the largest presence in the Nordic market. The customers consist of research institutes and hospitals. Optomed is headquartered in Oulu.
Read moreMarket cap
76.9M EUR
Turnover
300.09K EUR
P/E (adj.) (25e)
EV/EBIT (adj.) (25e)
P/B (25e)
EV/S (25e)
Dividend yield-% (25e)
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
6.5.
2025
Interim report Q1'25
7.8.
2025
Interim report Q2'25
6.11.
2025
Interim report Q3'25
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Redeye: Optomed Q4 - Quarter in line with expectations
Optomed Oyj: Optomed Plc: Financial Statements Bulletin, January - December 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Optomed Oyj: Proposal of Optomed's Nomination Board
